Inappropriate low dosing of direct oral anticoagulants in older patients with non-valvular atrial fibrillation: Impact on plasma drug levels

被引：3
|
作者：
Comans, Anne-Lore [1 ]
Sennesael, Anne-Laure [2 ]
Bihin, Benoit [3 ]
Regnier, Maxime [3 ]
Mullier, Francois [4 ]
Saint-Hubert, Marie de [5 ]
机构：
[1] Catholic Univ Louvain, CHU UCL Namur, Geriatr Dept, Yvoir, Belgium
[2] Catholic Univ Louvain, CHU UCL Namur, Namur Thrombosis & Hemostasis Ctr NTHC, Dept Pharm, Yvoir, Belgium
[3] Catholic Univ Louvain, CHU UCL Namur, Sci Support Unit, Yvoir, Belgium
[4] Catholic Univ Louvain, CHU UCL Namur, Namur Thrombosis & Hemostasis Ctr NTHC, NARILIS,Hematol Lab, Yvoir, Belgium
[5] Catholic Univ Louvain, CHU UCL Namur, Inst Rech Santa Soc, NARILIS,Geriatr Dept, Yvoir, Belgium
来源：
THROMBOSIS RESEARCH | 2021年 / 201卷
关键词：
Direct oral anticoagulants; Inappropriate prescription; Low dose; Drug monitoring; SAFETY;
D O I：
10.1016/j.thromres.2021.02.034
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：139 / 142
页数：4
相关论文
共 50 条
  • [21] ORal anticoaGulants in diAbetic and Nondiabetic patients with nOn-valvular atrial fibrillatioN (ORGANON)
    Derosa, Giuseppe
    Rizzo, Manfredi
    Brunetti, Natale Daniele
    Raddino, Riccardo
    Gavazzoni, Mara
    Pasini, Gianfranco
    Gaudio, Giovanni
    Maggi, Antonio
    D'Angelo, Angela
    De Gennaro, Luisa
    Maffioli, Pamela
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (08)
  • [22] Emerging oral anticoagulants for stroke prevention in patients with non-valvular atrial fibrillation
    Destephan, C.
    Waller, A. H.
    Patel, R. J.
    Dhruvakumar, S.
    Mazza, V.
    Gerula, C.
    Maher, J.
    Kaluski, E.
    [J]. MINERVA CARDIOANGIOLOGICA, 2012, 60 (04): : 425 - 431
  • [23] Indirect Comparisons of the New Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation
    Zolfaghari, Shabnam, Jr.
    Harenberg, Job
    Marx, Svetlana
    Wehling, Martin
    [J]. BLOOD, 2012, 120 (21)
  • [24] New oral anticoagulants for the prevention of stroke in patients with non-valvular atrial fibrillation
    Bosch, Montserrat
    Llop, Roser
    Lalueza, Pilar
    del Mar Villar, Maria
    [J]. MEDICINA CLINICA, 2013, 140 (05): : 229 - 231
  • [25] Low prevalence of colonic mucosal injury and bleeding in patients taking direct oral anticoagulants for non-valvular atrial fibrillation
    Osumi, Shun
    Abe, Koichiro
    Arizumi, Toshihiko
    Watari, Yuji
    Kozuma, Ken
    Aiso, Mitsuhiko
    Asaoka, Yoshinari
    Kodashima, Shinya
    Yamamoto, Takatsugu
    Tanaka, Atsushi
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (10) : 662 - 667
  • [26] Risk of ischemic stroke associated with direct oral anticoagulants discontinuation on patients with non-valvular atrial fibrillation
    Thomsen, T. Alvaro
    Guadalupe, J. Mesa
    Huerta, C.
    de Burgos, A.
    Soriano, L. Cea
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
  • [27] Impact of renal function on bleeding risk in patients with non-valvular atrial fibrillation treated with direct oral anticoagulants: Subanalysis of the DIRECT registry
    Hirata, A.
    Sotomi, Y.
    Kobayashi, T.
    Amiya, R.
    Hirayama, A.
    Higuchi, Y.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 2957 - 2957
  • [28] DEMOGRAPHIC AND SOCIOECONOMIC CHARACTERISTICS THAT IMPACT SELECTION OF ORAL ANTICOAGULANTS AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS
    Keshishian, A.
    Du, J.
    Xie, L.
    Yuce, H.
    Baser, O.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A55 - A55
  • [29] Novel Anticoagulants for Non-valvular Atrial Fibrillation
    Xu, Bo
    Whitbourn, Robert
    [J]. HEART LUNG AND CIRCULATION, 2012, 21 (08): : 463 - 467
  • [30] Direct oral anticoagulants in patients with cardiac implantable devices and non-valvular atrial fibrillation: the complexity of dose adjustments and the impact on outcomes
    Santos, J. M.
    Mendes, A. R.
    Rocha, M. J.
    Goncalves, L.
    Antonio, N.
    Fortuna, A.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2020, 50 : 47 - 47
12345